Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Orange Photonics: New High-Tech Testing For Psychedelic Products
October 20, 2023
Tags
News
Markets
Offerings
From
Benzinga
Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business
October 20, 2023
Tickers
CYBN
DMT
DMTTF
Tags
Earnings
News
M&A
From
Benzinga
Congress Halts Hearing On Psychedelics & Veterans As House Speaker Drama Continues
October 20, 2023
Tags
Legal
Management
News
From
Benzinga
New Survey Suggests Psilocybin Eases Psychological Distress From Childhood Trauma
October 19, 2023
Tags
Childhood trauma
News
Psychedelics
From
Benzinga
EXCLUSIVE: Reason For Hope On Veteran Group Efforts, Comments To FDA & 2023 Expectations
October 18, 2023
Tags
Reason for Hope
Psychedelics
Market News
From
Benzinga
Lucy Scientific's Fiscal Year: Operating Expenses Rise As Accumulated Deficit Hits Over $44M
October 17, 2023
Tickers
LSDI
Tags
fiscal year results
Psychedelics
Earnings
From
Benzinga
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
October 16, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
Ketamine Treatment
Psychedelic/Assisted Therapies
Penny Stocks
From
Benzinga
U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy
October 15, 2023
Tickers
AWKNF
Tags
News
Drug Science
ScholarGPS
From
Benzinga
Dem Presidential Candidate Calls For Universal Healthcare, Including Psychedelics Therapy
October 13, 2023
Tags
Cannabis
Market News
Benzinga
From
Benzinga
Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates
October 13, 2023
Tickers
CYBN
DMTTF
Tags
DMTTF
Markets
M&A
From
Benzinga
Pioneering Hope: Inside The Veteran's Organization Advancing Psychedelics Reform Policy
October 12, 2023
Tags
Management
Legal
Interview
From
Benzinga
EXCLUSIVE: Understanding Real Estate For Psychedelic Treatments Boosted By Geospatial Mapping
October 07, 2023
Tickers
AAPL
IBM
Tags
Tyler Zakovich
News
Management
From
Benzinga
EXCLUSIVE: The Need To Enhance Psychedelic Therapy Infrastructure, Data-Driven Solutions
October 06, 2023
Tags
Cody Shandraw
Markets
Healing Realty Trust
From
Benzinga
Maine's Portland Leads Drug Policy Reform, Decriminalizing Psychedelic Plants And Fungi
October 04, 2023
Tags
Psychedelics
Management
Legal
From
Benzinga
Decoding Insurance Reimbursement For Psychedelic-Assisted Therapy With BrainFutures Guide
October 04, 2023
Tags
Cannabis
Markets
Psychedelic Therapy Reimbursement
From
Benzinga
Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation
October 03, 2023
Tickers
ATAI
Tags
ATAI
Management
News
From
Benzinga
Cybin Completes Dosing In Phase 2 Study Of CYB003 For Major Depressive Disorder Treatment
October 03, 2023
Tickers
CYBN
Tags
Market News
Cannabis
Psychedelic/Assisted Therapies
From
Benzinga
Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares
October 03, 2023
Tickers
BNOX
CYBN
MRK
Tags
CYBN
Steve Cohen
Psychedelics
From
Benzinga
Insider's Look At Psychedelics Industry On Risk Management, Gray Market & Cannabis Industry
October 03, 2023
Tags
Psychedelics
Health Insurance
Psychedelic/Assisted Therapies
From
Benzinga
GH Research's Psychedelic Drug Candidate For Depression Meets FDA: Clinical Program On Hold
October 02, 2023
Tickers
GHRS
Tags
Cannabis
Markets
Investigational New Drug Application
From
Benzinga
Gov Newsom Green Lights Medical Psychedelics If Rescheduled And New Marijuana Testing Rules
October 02, 2023
Tags
Psychedelic/Assisted Therapies
Benzinga
Gov/ Gavin Newsom
From
Benzinga
Psychedelic Therapy Providers: Risk Management Perspective From A Cannabis Insurance Specialist
October 02, 2023
Tags
Benzinga
Psychedelic/Assisted Therapies
Cannabis
From
Benzinga
Argentina's Nacho Bottinelli On Psychedelics In Latin America: 'Brazil Opened A Giant Portal To Me'
October 02, 2023
Tags
Exclusives
Markets
News
From
Benzinga
Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
October 02, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
TheraPsil
LSDI
ATAI
From
Benzinga
Psychedelics Reform Update: Massachusetts, Pennsylvania, Maine, California, Michigan, Minnesota, Indiana
September 30, 2023
Tags
Psychedelic/Assisted Therapies
Benzinga
Market News
From
Benzinga
PharmaTher Is 'One Step Closer To Being A Ketamine Leader' Due To FDA Acceptance
September 27, 2023
Tickers
PHRRF
Tags
News
General
Guidance
From
Benzinga
Cybin And Fluence Partner To Support EMBARK Training For Phase 3 CYB003 Trial For Depression
September 26, 2023
Tickers
CYBN
Tags
Fluence
Markets
Guidance
From
Benzinga
Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results
September 26, 2023
Tickers
CYBN
DMTTF
Tags
CYBN
Management
News
From
Benzinga
Defense Dept. Grants $1M To Yale & Transcend Therapeutics To Study PTSD Therapy
September 26, 2023
Tags
Yale University
Psychedelic/Assisted Therapies
Transcend Therapeutics
From
Benzinga
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
September 26, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
DMTTF
JAGX
ENVB
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.